Are we investing in sexual and reproductive health products that people want to use?
On World Contraception Day, the importance of choice in the realm of sexual and reproductive health cannot be overstated Comprehensive sexual and reproductive [...]
The Future of the Modern Contraceptive Method Mix: Innovative Technology, User-Focused Design
FP2030 and the CTI Exchange, in partnership with Population Council, PSI, RHSC, and FHI 360, will host an exploration of innovative contraceptive technology, including [...]
Biomedical Development
Despite the increased use of modern contraception globally over the past 50 years, approximately 48% of all pregnancies are unintended and more than [...]
Products in Development
More than 170 million women around the world use contraceptives developed by the Center for Biomedical Research (CBR) or based on our technologies. Still, [...]
Novel Intravaginal Ring as a Non-Hormonal Contraceptive
There is an undeniable need for new technologies to address the overlapping global burdens of unintended pregnancy and sexually transmitted infections (STIs) such [...]
Lisa Haddad
Lisa Haddad is medical director of the Center for Biomedical Research at the Population Council. She leads the clinical development efforts to advance [...]
Barbara Friedland
Barbara Friedland, MPH is a Senior Associate at the Population Council’s Center for Biomedical Research based in New York. Since joining the Council [...]
Partner with Us
In collaboration with governments, service providers, civil society organizations, and other partners, we conduct pioneering research and develop innovative products and tools across [...]
Sexual and Reproductive Health, Rights, and Choices
The Population Council tackles intersecting inequalities that undermine rights and access to contraception, HIV and STI prevention, maternal and newborn health, safe abortion, [...]
CBR News and Highlights
Biomedical Bulletin Newsletters June 2025 April 2025 December 2024 September 2024 July 2024 February 2024 November 2023 July 2023 April 2023 Press Releases [...]
Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic
September 12, 2023 – Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that it has entered into an [...]
World Contraception Day
From IUDs to implants and vaginal rings, our Center for Biomedical Research (CBR) has brought nine products to market. More than 170 million [...]